Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   MYLAN
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
MYLAN
Dec-18
PANACEA BIOTECH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1913,967-   
Low Rs1072,184-   
Sales per share (Unadj.) Rs75.11,825.4-  
Earnings per share (Unadj.) Rs-5.549.6-  
Cash flow per share (Unadj.) Rs0.9391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs137.71,974.7-  
Shares outstanding (eoy) m61.25514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.7 118.0%   
Avg P/E ratio x-27.162.0 -43.7%  
P/CF ratio (eoy) x170.07.9 2,163.2%  
Price / Book Value ratio x1.11.6 69.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m9,1421,582,214 0.6%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m1,2650-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m4,599939,158 0.5%  
Other income Rs m5170-   
Total revenues Rs m5,116939,158 0.5%   
Gross profit Rs m47243,019 0.0%  
Depreciation Rs m391175,847 0.2%   
Interest Rs m4445,170 0.1%   
Profit before tax Rs m12822,002 0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m466-3,500 -13.3%   
Profit after tax Rs m-33725,502 -1.3%  
Gross profit margin %1.025.9 4.0%  
Effective tax rate %363.5-15.9 -2,285.0%   
Net profit margin %-7.32.7 -270.2%  
BALANCE SHEET DATA
Current assets Rs m5,623524,425 1.1%   
Current liabilities Rs m3,297382,364 0.9%   
Net working cap to sales %50.615.1 334.3%  
Current ratio x1.71.4 124.3%  
Inventory Days Days5984 70.3%  
Debtors Days Days4893 51.1%  
Net fixed assets Rs m7,028182,181 3.9%   
Share capital Rs m61500 12.2%   
"Free" reserves Rs m8,3750-   
Net worth Rs m8,4361,015,998 0.8%   
Long term debt Rs m2021,096,588 0.0%   
Total assets Rs m12,7122,725,301 0.5%  
Interest coverage x3.91.5 261.3%   
Debt to equity ratio x01.1 2.2%  
Sales to assets ratio x0.40.3 105.0%   
Return on assets %-2.32.6 -88.9%  
Return on equity %-4.02.5 -159.4%  
Return on capital %2.03.2 62.8%  
Exports to sales %43.30-   
Imports to sales %24.40-   
Net fx Rs m8010-   
CASH FLOW
From Operations Rs m-4,225195,157 -2.2%  
From Investments Rs m4,303-100,875 -4.3%  
From Financial Activity Rs m-184-90,916 0.2%  
Net Cashflow Rs m-1051,617 -6.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare PANACEA BIOTECH With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: ALKEM LABORATORIES  SUVEN LIFE SCIENCES  PLETHICO PHARMA  VINEET LABORATORIES  BH.IMMUN&BIO  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.